7:00 am Stemline Therapeutics announces FDA acceptance of IND for SL-701, a synthetic multi-peptide vaccine targeting glioma brain tumors
View todays social media effects on STML
View the latest stocks trending across Twitter. Click to view dashboard
See who Stemline is hiring next, click here to view
